Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome

Genes Chromosomes and Cancer

Volumn 43, Issue 4, 2005, Pages 383-389

  Fisher, Andrew M ^a   Strike, Paul ^a   Scott, Claire ^b   Moorman, Anthony V ^c  

^a SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; GC RICH SEQUENCE; GENE FREQUENCY; GENE LOCATION; GENETIC VARIABILITY; GENOME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

BASE COMPOSITION; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DATABASES, FACTUAL; GENOME, HUMAN; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; TRANSLOCATION, GENETIC;

EID: 21744442745     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20196     Document Type: Article

References (33)

1. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH. 1999. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood 93:4131-143.
2. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voute PA, Heisterkamp S, van Kampen A, Versteeg R. 2001. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 29:1289-92.
3. Cohen O, Cans C, Cuillel M, Gilardi JL, Roth H, Mermet MA, Jalbert P, Demongeot J. 1996. Cartographic study: breakpoints in 1574 families carrying human reciprocal translocations. Hum Genet 97:659-667.
4. Daniel A. 1979. Structural differences in reciprocal translocations. Potential for a model of risk in Rep. Hum Genet 51:171-182.
5. De Braekeleer M. 1987. Variant Philadelphia translocations in chronic myeloid leukemia. Cytogenet Cell Genet. 44:215-222.
6. Deininger MW, Goldman JM, Melo JV. 2000. The molecular biology of chronic myeloid leukemia. Blood 96:3343-3356.
7. D'Onofrio G. 2002. Expression patterns and gene distribution in the human genome. Gene 300:155-60.
8. Fullerton SM, Bernardo Carvalho A, Clark AG. 2001. Local rates of recombination are positively correlated with GC content in the human genome. Mol Biol Evol 18:1139-1142.
9. Gallego M, Carroll AJ, Gad GS, Pappo A, Head D, Behm F, Ravindranath Y, Raimondi SC. 1994. Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood. Cancer Genet Cytogenet 75:139-44.
10. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA. 2004a. Chromacin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 118:555-566.
11. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison CJ, Harrison G, Rees JKH, Hann IM, Stevens RF, Burnett AK, Goldstone AH, Medical Research Council Adult and Children's Leukaemia Working Parties. 1998. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322-2333.
12. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berget R, Neat M, Howe K, Dastugue N, Jansen J, Radford-Weiss I, Lo Coco F, Lessard M, Hernandez JM, Delabesse E. Head D, Liso V, Sainty D, Flandrin G, Solomon E, Birg F, Lafage-Pochitaloff M. 2000. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 96:1297-1308.
13. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, Wheatley K, Burnett AK, Goldstone AH. 2001. The predictive value of hierarchical cytogenetic classification in older patients with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98:1312-1320.
14. Groupe Français de Cytogénétique Hématologique 1990. Acute myelogenous leukemia with an 8;21 translocation. A report on 148 cases from the Groupe Francais de Cytogénétique Haematologique. Cancer Genet Cytogenet 44:169-79.
15. Hecht F. 1988. Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands. Cancer Genet Cytogenet 31:17-24.
16. Heim S, Mitelman F. 1995. Cancer Cytogenetics, Second Ed. New York: Wiley-Liss.
17. Heim S, Billstrom R, Kristoffersson U, Mandahl N, Strombeck B, Mitelman F. 1985. Variant Ph translocations in chronic myeloid leukemia. Cancer Genet Cytogenet 18:215-227.
18. Huret JL, Tanzer J, Henry-Amar M. 1986. Aberrant breakpoints in chronic myelogenous leukaemia; oncogenes and fragile sites. Hum Genet 74:447-448.
19. International Human Genome Sequencing Consortium 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-945.
20. ISCN. 1995. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel, Switzerland: S. Karger.
21. Ishihara T, Minamihisamatsu M. 1988. The Philadelphia chromosome. Considerations based on studies of variant Ph translocations. Cancer Genet Cytogenet 32:75-92.
22. Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, Morris CM. 1998. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet. 7:767-776.
23. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K. 2002. A high-resolution recombination map of the human genome. Nat Genet 31:241-247.
24. Maseki N, Miyoshi H, Shimizu K, Homma C, Ohki M, Sakurai M, Kaneko Y. 1993. The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood 81:1573-1579.
25. Moorman AV, Roman E, Cartwright RA, Morgan GJ. 2002. Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK. Clin Lab Haematol 24:263-265.
26. O'Brien S, Thall PF, Siciliano MJ. 1997. Cytogenetics of chronic myelogenous leukaemia. Baillieres Clin Haematol 10:259-276.
27. Paces J, Zika R, Paces V, Pavlicek A, Clay O, Bernardi G. 2004. Representing GC variation along eukaryotic chromosomes. Gene 333:135-141.
28. Pavlicek A, Paces J, Clay O, Bernardi G. 2002. A compact view of isochores in the draft human genome sequence. FEBS Lett 511:165-169.
29. Sandberg AA. 1980. Chromosomes and causation of human cancer and leukemia: XL. The Ph1 and other translocations in CML. Cancer 46:2221-2226.
30. Stoll C. 1980. Nonrandom distribution of exchange points in patients with reciprocal translocations. Hum Genet 56:89-93.
31. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO et al. 2001. The sequence of the human genome. Science 292:1838.
32. Versteeg R, van Schaik BD, van Batenburg MF, Roos M, Monajemi R, Caron H, Bussemaker HJ, van Kampen AH. 2003. The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes. Genome Res 13:1998-2004.
33. Warburton D. 1991. De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. Am J Hum Genet 49:995-1013.